Brand name · Immunology / IL-12/23
Stelara (Ustekinumab) J-Code / HCPCS Code
In short
Stelara is billed under HCPCS J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg. One billing unit is 1 mg.
J3357 covers the subcutaneous formulation. The intravenous formulation has a separate code (J3358). Ustekinumab biosimilars are listed under their own names.
Reference
- Code
- J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mgMed-Code curated
- Billing unit
- 1 mg
- Same code in the directory
- Ustekinumab
- Pharmacologic class
- Interleukin-12 Antagonist; Interleukin-23 AntagonistFrom the FDA listings below
- Labelers
- Janssen Biotech, Inc.
- J-code category
- Immunology / IL-12/23
FDA-listed products
Finished products whose name and route match this directory entry.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Stelaraustekinumab | Ustekinumab 45 mg/.5mL | Injection, SolutionSubcutaneous | Janssen Biotech, Inc. | 57894-060 |
| Stelaraustekinumab | Ustekinumab 90 mg/mL | Injection, SolutionSubcutaneous | Janssen Biotech, Inc. | 57894-061 |
Other products with this name
Same name but a different route, formulation or combination — the code above does not apply to these.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Stelaraustekinumab | Ustekinumab 130 mg/26mL | SolutionIntravenous | Janssen Biotech, Inc. | 57894-054 |